Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)

NCT01199861 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: Fingolimod
DRUG: Placebo
BIOLOGICAL: Seasonal influenza vaccine
BIOLOGICAL: Tetanus toxoid vaccine

Sponsor

Novartis